Intratumoral TRM share characteristics with previously identified pathogen-specific TRM. These CD8+ T cells express adhesion receptors such as CD103 that provide interactions with surrounding tumor cells and downregulate migratory pathways that facilitate entry into the circulation. The gene discussed is CD8A; the disease is neoplasm.